admin

13
Mar

EU CTR 2025: What It Means for Clinical Trials & Supply Chain

The European Union (EU) Clinical Trials Regulation (CTR) officially

6
Mar

How US Tariffs Are Reshaping the Pharmaceutical Supply Chain

The United States’ recent escalation in tariff policies, particularly

24
Feb

Top Breakthrough Medications to Watch in 2025

Which new market entrants should be on the industry’s radar

13
Feb

How the Trump Administration’s Drug Pricing Policies Will Reshape Pharma

The pharmaceutical sector has been a major focus for the Trump Administration,

5
Feb

The Shift in Pharma M&A: Moving Towards Targeted, High-Impact Deals

In 2024, life sciences companies pivoted away from large-scale mergers

10
Jan

Key Investments & Mergers Reshaping CDMO/CMO Landscape in 2024

As 2024 nears its end, the contract development and manufacturing organization (CDMO)